Black Ben E, Vitto Michael J, Gioeli Daniel, Spencer Adam, Afshar Nima, Conaway Mark R, Weber Michael J, Paschal Bryce M
Center for Cell Signaling, Department of Biochemistry and Molecular Genetics, Box 800577 Health Systems, University of Virginia, Charlottesville, VA 22908, USA.
Mol Endocrinol. 2004 Apr;18(4):834-50. doi: 10.1210/me.2003-0145. Epub 2003 Dec 18.
Here we report that mutations within the DNA-binding domain of AR, shown previously to inhibit nuclear export to the cytoplasm, cause an androgen-dependent defect in intranuclear trafficking of AR. Mutation of two conserved phenylalanines within the DNA recognition helix (F582, 583A) results in androgen-dependent arrest of AR in multiple subnuclear foci. A point mutation in one of the conserved phenylalanines (DeltaF582, F582Y) is known to cause androgen insensitivity syndrome (AIS). Both AIS mutants (DeltaF582, F582Y) and the export mutant (F582, 583A) displayed androgen-dependent arrest in foci, and all three mutants promoted androgen-dependent accumulation of the histone acetyl transferase CREB binding protein (CBP) in the foci. The foci correspond to a subnuclear compartment that is highly enriched for the steroid receptor coactivator glucocorticoid receptor-interacting protein (GRIP)-1. Agonist-bound wild-type AR induces the redistribution of GRIP-1 from foci to the nucleoplasm. This likely reflects a direct interaction between these proteins because mutation of a conserved residue within the major coactivator binding site on AR (K720A) inhibits AR-dependent dissociation of GRIP-1 from foci. GRIP-1 also remains foci-associated in the presence of agonist-bound F582, 583A, DeltaF582, or F582Y forms of AR. Two-dimensional phospho-peptide mapping and analysis with a phospho-specific antibody revealed that mutant forms of AR that arrest in the subnuclear foci are hypophosphorylated at Ser81, a site that normally undergoes androgen-dependent phosphorylation. Our working model is that the subnuclear foci are sites where AR undergoes ligand-dependent engagement with GRIP-1 and CBP, a recruitment step that occurs before Ser81 phosphorylation and association with promoters of target genes.
在此我们报告,雄激素受体(AR)DNA结合域内的突变,先前已证明其可抑制核输出至细胞质,却导致了AR在细胞核内运输过程中出现雄激素依赖性缺陷。DNA识别螺旋内两个保守苯丙氨酸的突变(F582、583A)导致AR在多个核内小体中出现雄激素依赖性停滞。已知其中一个保守苯丙氨酸的点突变(ΔF582、F582Y)会导致雄激素不敏感综合征(AIS)。AIS突变体(ΔF582、F582Y)和输出突变体(F582、583A)在小体中均表现出雄激素依赖性停滞,且所有这三种突变体均促进了组蛋白乙酰转移酶CREB结合蛋白(CBP)在小体中的雄激素依赖性积累。这些小体对应于一个核内亚区室,该亚区室高度富集类固醇受体共激活因子糖皮质激素受体相互作用蛋白(GRIP)-1。激动剂结合的野生型AR诱导GRIP-1从小体重新分布至核质。这可能反映了这些蛋白质之间的直接相互作用,因为AR上主要共激活因子结合位点内一个保守残基的突变(K720A)会抑制GRIP-1从AR依赖性小体中解离。在存在激动剂结合的F582、583A、ΔF582或F582Y形式的AR时,GRIP-1也仍与小体相关。二维磷酸肽图谱分析以及使用磷酸特异性抗体进行的分析表明,在核内小体中停滞的AR突变形式在Ser81位点磷酸化不足,该位点通常会发生雄激素依赖性磷酸化。我们的工作模型是,核内小体是AR与GRIP-1和CBP进行配体依赖性结合的位点,这是一个在Ser81磷酸化以及与靶基因启动子结合之前发生的募集步骤。